Exact Mass: 392.0500606
Exact Mass Matches: 392.0500606
Found 152 metabolites which its exact mass value is equals to given mass value 392.0500606,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Epithienamycin E
C13H16N2O8S2 (392.03480559999997)
A member of the class of carbapenems that is (5R,6R)-3-{[(E)-2-aminoethenyl]sulfanyl}-6-[(1S)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid in which the free hydroxy and amino groups are carrying sulfo and acetyl substituents respectively. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D013845 - Thienamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Tiotropium
C19H22NO4S2+ (392.09901920000004)
Tiotropium is a long-acting, 24 hour, anticholinergic bronchodilator used in the management of chronic obstructive pulmonary disease (COPD). Tiotropium is a muscarinic receptor antagonist, on topical application it acts mainly on M3 muscarinic receptors located in the airways to produce smooth muscle relaxation, thus producing a bronchodilatory effect.
beta-D-3-[5-Deoxy-5-(dimethylarsinyl)ribofuranosyloxy]-2-hydroxy-1-propanesulfonic acid
C10H21AsO9S (392.01221960000004)
beta-D-3-[5-Deoxy-5-(dimethylarsinyl)ribofuranosyloxy]-2-hydroxy-1-propanesulfonic acid is found in green vegetables. beta-D-3-[5-Deoxy-5-(dimethylarsinyl)ribofuranosyloxy]-2-hydroxy-1-propanesulfonic acid is isolated from the edible brown seaweeds ishimozuku (Sphaerotrichia divaricata), makonbu (Laminaria japonica) and hijiki (Hizikia fusiforme
Calcium ascorbate
Antioxidant. Calcium ascorbate is a compound with formula CaC12H14O12. It is the calcium salt of ascorbic acid. Antioxidant
Actos
C19H20N2O3S.HCl (392.0961346000001)
Pioglitazone hydrochloride is an aromatic ether. Pioglitazone Hydrochloride is the hydrochloride salt of an orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic activity. Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-gamma), a ligand-activated transcription factor, thereby inducing cell differentiation and inhibiting cell growth and angiogenesis. This agent also modulates the transcription of insulin-responsive genes, inhibits macrophage and monocyte activation, and stimulates adipocyte differentiation. (NCI05) A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS. See also: Pioglitazone (has active moiety); Glimepiride; Pioglitazone Hydrochloride (component of); Alogliptin Benzoate; Pioglitazone Hydrochloride (component of). C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent D007004 - Hypoglycemic Agents Pioglitazone hydrochloride is a potent and selective PPARγ agonist with EC50s of 0.93 and 0.99 μM for human and mouse PPARγ, respectively.
Hosloppin
ethyl 3-[(ethoxycarbonyl)methyl]-4,6-dihydro-8,9-dihydroxy-2,6-dioxo-2H-pyrano[3,4,5-de]chromene-4-carboxylate|pomegranatate
Rhodolauradiol acetate|Rhodolauradiol monoacetate
C17H26BrClO3 (392.07537360000003)
2-C-??-D-Xylopyranosyl-1,3,6,7-tetrahydroxyxanthone
2-chloro-3,8-dihydroxy-1,4,6,9-tetramethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepine-7-carboxylic acid methyl ester|hypophysciosporin
4,5,7-trihydroxy-6-(3,4-dihydroxybenzyl)flavone|6-(3,4-dihydroxybenzyl)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one
[5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4-oxo-4H-chromen-8-yl]sulfonic acid monoether
beta-D-3-[5-Deoxy-5-(dimethylarsinyl)ribofuranosyloxy]-2-hydroxy-1-propanesulfonic acid
C10H21AsO9S (392.01221960000004)
2h,2h,3h,3h-perfluorononanoic acid
C9H5F13O2 (392.00819459999997)
Acetamide,N-[[5-amino-2-[(4-aminophenyl)sulfonyl]phenyl]sulfonyl]-, sodium salt (1:1)
Methyl 4-acetoxy-8-{[(trifluoromethyl)sulfonyl]oxy}-2-naphthoate
Metaclazepam
C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
9,10-Anthracenedione,1-amino-2-bromo-4-(phenylamino)-
2,7-Diphenyl[1]benzothieno[3,2-b][1]benzothiophene
Adenosine, 2-chloro-8-(methylamino)-, cyclic 3,5-(hydrogen phosphate)
C11H14ClN6O6P (392.04009440000004)
Anthra[2,1,9-def:6,5,10-def]diisochromene-1,3,8,10-tetraone
Edetate calcium disodium monohydrate
D064449 - Sequestering Agents > D002614 - Chelating Agents > D065096 - Calcium Chelating Agents D000074385 - Food Ingredients > D005503 - Food Additives D006401 - Hematologic Agents > D000925 - Anticoagulants
Parecoxib sodiuM
C19H17N2NaO4S (392.0806682000001)
D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents
4-(TRIFLUOROMETHYL)UMBELLIFERYL-BETA-D-GLUCOPYRANOSIDE
Ethyl 4-(3-iodo-1H-pyrrolo[2,3-b]pyridin-5-yl)benzoate
METHYL 1-(4-(TRIFLUOROMETHYL)PHENYL)-5-(4-(METHYLTHIO)PHENYL)-1H-PYRAZOLE-3-CARBOXYLATE
N-[2-(4-oxo-4H-3,1-benzoxazin-2-yl)phenyl]-p-toluenesulphonamide
C21H16N2O4S (392.08307360000003)
((2R,3R,4R,5R)-3-(benzoyloxy)-5-chloro-4-fluoro-4-methyltetrahydrofuran-2-yl)methyl benzoate
BIS(ETHYLCYCLOPENTADIENYL)COBALT(III)
C14H20CoF6P (392.05387220000006)
((2R,3R,4R,5S)-3-(benzoyloxy)-5-chloro-4-fluoro-4-methyltetrahydrofuran-2-yl)methyl benzoate
4-(trifluoromethyl)umbelliferyl-beta-d-galactopyranoside
PX-478 2HCl
C13H20Cl4N2O3 (392.0227970000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
6-(Bis-(2,2,2-trifluoroethyl)amino)-4-trifluoromethyl-1H-quinolin-2-one
C14H9F9N2O (392.05711319999995)
2-Propanesulfonamide, N-((3S,4S)-4-(4-(5-cyano-2-thienyl)phenoxy)tetrahydro-3-furanyl)-
C18H20N2O4S2 (392.08644400000003)
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Pesampator (PF-04958242) is a potent and highly selective positive allosteric modulator of AMPA receptor (an AMPA potentiator) with an EC50 of 310 nM and a Ki of 170 nM[1].
Benzyl 6-Benzyl-5,7-Dioxo-6,7-Dihydro-5h-[1,3]thiazolo[3,2-C]pyrimidine-2-Carboxylate
C21H16N2O4S (392.08307360000003)
Propane-2,2-diylbis(4,1-phenylene) bis(sulfurofluoridate)
C15H14F2O6S2 (392.01998480000003)
4-(5-methyl-2-furanyl)-2-[[1-oxo-2-(1H-1,2,4-triazol-5-ylthio)ethyl]amino]-3-thiophenecarboxylic acid ethyl ester
2-[[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]methylthio]-6-phenyl-1H-pyrimidin-4-one
Methyl 6,11-dihydro-6,11-dioxo-2-ethyl-5,7,9-trihydroxy-1-naphthacenecarboxylate
Tiotropium
C19H22NO4S2+ (392.09901920000004)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists
4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline
phosphono 4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoate
N-Pyridoxyl-2-methyl-L-glutamic acid-5-monophosphate
Pioglitazone Hydrochloride
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent D007004 - Hypoglycemic Agents Pioglitazone hydrochloride is a potent and selective PPARγ agonist with EC50s of 0.93 and 0.99 μM for human and mouse PPARγ, respectively.
calcium;2-(1,2-dihydroxyethyl)-3,4-dihydroxy-2H-furan-5-one
2-[[4-(4-Fluorophenyl)-6-(trifluoromethyl)-2-pyrimidinyl]sulfonyl]acetic acid ethyl ester
N-(2-furanylmethyl)-5-thiophen-2-yl-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinecarboxamide
2-Thiophenecarboxylic acid [3-(3,5-dimethylphenoxy)-4-oxo-1-benzopyran-7-yl] ester
C22H16O5S (392.07184060000003)
4-[[[4-(2-Furanylmethyl)-5-(thiophen-2-ylmethyl)-1,2,4-triazol-3-yl]thio]methyl]benzonitrile
C20H16N4OS2 (392.07654859999997)
2-[[5,6-bis(2-furanyl)-1,2,4-triazin-3-yl]thio]-N-(3-methylphenyl)acetamide
3-(4-amino-3,5-dichlorobenzoyl)-2-(3-amino-3-oxopropyl)-2H-indazole 1-oxide
2-(1,4-dioxo-3H-phthalazin-2-yl)-N-(5-methyl-4-phenyl-2-thiazolyl)acetamide
N-(2-methoxyphenyl)-2-(2-oxopropylthio)-1,3-benzoxazole-5-sulfonamide
2-[[2-(5-Methyl-2-thiophenyl)-2-oxoethyl]thio]-3-phenyl-4-quinazolinone
C21H16N2O2S2 (392.06531559999996)
(2E)-5-{3-[(difluoromethyl)sulfanyl]benzyl}-2-[(2E)-(pyridin-2-ylmethylidene)hydrazinylidene]-1,3-thiazolidin-4-one
C17H14F2N4OS2 (392.05770579999995)
(4-oxopyrimido[2,1-b][1,3]benzothiazol-2-yl)methyl (E)-3-(4-methoxyphenyl)prop-2-enoate
C21H16N2O4S (392.08307360000003)
(2E)-5-[[4-(difluoromethylsulfanyl)phenyl]methyl]-2-[(E)-pyridin-3-ylmethylidenehydrazinylidene]-1,3-thiazolidin-4-one
C17H14F2N4OS2 (392.05770579999995)
(6R,7S,8S)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8S)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8R)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8S)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8R)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8S)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8R)-7-(4-bromophenyl)-4-[cyclobutyl(oxo)methyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl] [(3R,4S,5S)-2,4,5-trihydroxyoxan-3-yl] hydrogen phosphate
C11H21O13P (392.07197460000003)
[4-[3-[3,5-dihydroxy-4-[(E)-3-methylbut-1-enyl]phenyl]oxiran-2-yl]phenyl] hydrogen sulate
C19H20O7S (392.09296900000004)
agrocinopine B
C11H21O13P (392.07197460000003)
A member of the class of agrocinopines that consists of beta-D-fructose and L-arabinose units joined via a phosphodiester linkage between position 4 of fructose and position 2 of arabinose.
Inosinic acid (disodium)(hydrate)(1:2:X)
Inosinic acid (disodium)(hydrate)(1:2:X) (5'-IMP (disodium)(hydrate)(1:2:X)) is an endogenous metabolite. Inosinic acid (disodium)(hydrate)(1:2:X) (5'-IMP (disodium)(hydrate)(1:2:X)) is an endogenous metabolite.
2,4,7-trihydroxy-2-(2-oxopropyl)-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-3-one
(2r,3s)-2-[(3,4-dihydroxyphenyl)methyl]-2-hydroxy-3-(4-hydroxybenzoyloxy)butanedioic acid
3-{[(1e)-2-[(1-hydroxyethylidene)amino]ethenyl]sulfanyl}-7-oxo-6-[1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
C13H16N2O8S2 (392.03480559999997)
3-({5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl}oxy)-2-hydroxypropane-1-sulfonic acid
C10H21AsO9S (392.01221960000004)
2'-acetyl-5-[2-(3,4-dihydroxyphenyl)ethenyl]-5',6'-dihydroxyspiro[furan-2,1'-inden]-3-one
2-c-β-d-xylopyranosyl-1,3,6,7-tetrahydroxy-xanthone
{"Ingredient_id": "HBIN005454","Ingredient_name": "2-c-\u03b2-d-xylopyranosyl-1,3,6,7-tetrahydroxy-xanthone","Alias": "NA","Ingredient_formula": "C18H16O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "22825","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(1s,2s,3's,4r,4's,6's)-3'-bromo-4'-chloro-1,3,3,4'-tetramethyl-7-oxaspiro[bicyclo[2.2.1]heptane-2,1'-cyclohexan]-6'-yl acetate
C17H26BrClO3 (392.07537360000003)
2-(3-chloro-2-hydroxyphenyl)-3,5,7,8-tetramethoxychromen-4-one
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(4-hydroxyphenyl)methyl]chromen-4-one
2,12,14,17-tetrahydroxy-4,9,9-trimethylpentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-1,3,5(18),7,11,13,15-heptaene-6,10,19-trione
1,3,6,7-tetrahydroxy-2-(3,4,5-trihydroxyoxan-2-yl)xanthen-9-one
(1r,2r,3'r,4s,4'r,6'r)-3'-bromo-4'-chloro-1,3,3,4'-tetramethyl-7-oxaspiro[bicyclo[2.2.1]heptane-2,1'-cyclohexan]-6'-yl acetate
C17H26BrClO3 (392.07537360000003)
3-({2-[(1-hydroxyethylidene)amino]ethenyl}sulfanyl)-7-oxo-6-[1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
C13H16N2O8S2 (392.03480559999997)
2-[(3,4-dihydroxyphenyl)methyl]-2-hydroxy-3-(4-hydroxybenzoyloxy)butanedioic acid
(5r,6r)-3-{[(1e)-2-[(1-hydroxyethylidene)amino]ethenyl]sulfanyl}-7-oxo-6-[1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
C13H16N2O8S2 (392.03480559999997)
(17r)-2,12,14,17-tetrahydroxy-4,9,9-trimethylpentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-1,3,5(18),7,11,13,15-heptaene-6,10,19-trione
1,3,6,7-tetrahydroxy-2-[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]xanthen-9-one
(17s,18r)-13,15,18-trihydroxy-14-(1-hydroxyethylidene)-17-methyl-8-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1,4,6,9,12,15,19-heptaene-3,11-dione
methyl 2-ethyl-5,7,10-trihydroxy-6,11-dioxotetracene-1-carboxylate
(2e)-1-(3-bromo-6-hydroxy-2,4-dimethoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
(2s)-3-{[(2r,3r,4s,5s)-5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl]oxy}-2-hydroxypropane-1-sulfonic acid
C10H21AsO9S (392.01221960000004)
(2r)-3-{[(2r,3r,4s,5s)-5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl]oxy}-2-hydroxypropane-1-sulfonic acid
C10H21AsO9S (392.01221960000004)
ethyl 4-(2-ethoxy-2-oxoethyl)-11,12-dihydroxy-3,8-dioxo-2,7-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),4,9(13),10-tetraene-6-carboxylate
(2r)-2,4,7-trihydroxy-2-(2-oxopropyl)-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-3-one
2'-acetyl-5-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-5',6'-dihydroxyspiro[furan-2,1'-inden]-3-one
5,7-dihydroxy-3,6,8-trimethoxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
(17r,18s)-13,15,18-trihydroxy-14-(1-hydroxyethylidene)-17-methyl-8-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1,4,6,9,12,15,19-heptaene-3,11-dione
(3-{2,6-dibromo-4-[2-(methylamino)ethyl]phenoxy}propyl)dimethylamine
C14H22Br2N2O (392.00987619999995)
9,19,21-trihydroxy-6-oxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁵,²⁰]henicosa-1(21),3,8,10,13,15(20),18-heptaene-2,7,12,16,17-pentone
6-[(3,4-dihydroxyphenyl)methyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one
(5r,6r)-3-{[(1e)-2-[(1-hydroxyethylidene)amino]ethenyl]sulfanyl}-7-oxo-6-[(1s)-1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
C13H16N2O8S2 (392.03480559999997)
3'-bromo-4'-chloro-1,3,3,4'-tetramethyl-7-oxaspiro[bicyclo[2.2.1]heptane-2,1'-cyclohexan]-6'-yl acetate
C17H26BrClO3 (392.07537360000003)